Clinical study to know the efficacy of Dhartripanaka in vomitting in pregnancy
Phase 2
- Conditions
- Health Condition 1: K929- Disease of digestive system, unspecifiedHealth Condition 2: K319- Disease of stomach and duodenum, unspecifiedHealth Condition 3: O210- Mild hyperemesis gravidarum
- Registration Number
- CTRI/2022/02/039970
- Lead Sponsor
- Sri Sri college of Ayurveda Science and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a) Subjects having confirm diagnosis of pregnancy.
b) Subjects presenting the classical symptoms of Garbhini chardi.
c) Subjects presenting with symptoms of Emesis Gravidarum.
d) Subjects diagnosed as Garbhini chardi in all trimester pregnancy.
e) Primigravida and multigravida.
Exclusion Criteria
a)Subjects with Hyper emesis gravidarum.
b) Vomiting caused due Intestinal infestation, Urinary tract infection.
c) Vomiting caused due to Peptic ulcer, Appendicitis.
d) Vomiting caused due Red degeneration fibroid, Twisted Ovarian tumour.
e) COVID-19 Positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dhatripanaka is effective in reducing nausea and vomitting <br/ ><br> <br/ ><br>Timepoint: On 8thday <br/ ><br>On 15th day <br/ ><br>On 30th day
- Secondary Outcome Measures
Name Time Method tablet Doxinate was proved to be effective in Garbhini Chardi w.s.r Emesis Gravidarum, which will be assessed by the scales with PQUE scaleTimepoint: 8thday, 15th day, 30th day